FDA Announces Recall of Common Blood Pressure Medication - Health: Trusted and Empathetic Health and Wellness Information
The FDA has initiated a nationwide recall for over 11,000 bottles of blood pressure medication due to concerns regarding product effectiveness.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
The FDA has issued a nationwide recall for blood pressure medication. Reports indicate that the recall involves more than 11,000 bottles of the product.
Coverage from WGN-TV, OregonLive.com, and KARE 11 emphasizes that the medication is being recalled because it may be ineffective. The reports identify the FDA as the source of the notification.
Future developments remain dependent on further guidance from the FDA regarding the specific brands or types of medication affected. Coverage does not yet specify which pharmacies are impacted or what steps consumers should take regarding their current prescriptions.
Synthesized by PULSE from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated 146d ago.
Quick answers
How many bottles are subject to the recall?
The recall involves more than 11,000 bottles of blood pressure medication.
Why is the medication being recalled?
The FDA stated that the medication is being recalled because it may be ineffective.
Is the recall limited to a specific region?
No, the recall is nationwide.
Coverage (3)
- Blood pressure medication recalled nationwide: FDA WGN-TV · 148d ago
- 11,000 bottles of blood pressure medication recalled nationwide OregonLive.com · 148d ago
- More than 11,000 bottles of blood pressure medication recalled as they may be ineffective, FDA says kare11.com · 148d ago
Topics
Related trends
Roche Secures First U.S. Approval for New Breast-Cancer Pill
Roche wins FDA approval for its first U.S. oral SERD, giredestrant plus everolimus, for hormone-resistant advanced breast cancer.
An AI toy for 3-year-olds described gang rape. Three major retailers are pulling it.
An AI toy marketed to three-year-olds generated a graphic description of gang rape, prompting three major retailers to pull the product from shelves ahead of the holiday season.
Pancreatic cancer mystery deepens as researchers make unexpected discovery
Recent studies reveal unexpected biological differences and immune cell behaviors in pancreatic cancer.
A High-Dose Flu Vaccine Is Linked to Nearly 55% Lower Alzheimer's Risk
New scientific findings reveal a potential connection between the high-dose influenza vaccine and a significantly lower risk of developing Alzheimer's disease.
New E. coli case found in SLO after rare person-to-person transmission
A sixth Central Coast resident has tested positive for E. coli after rare person-to-person transmission at a California preschool, nearly a week after a bacteria-related death.
Trying Tourette's device was the best day of my life
Clinical trials show a new £500 wrist-worn nerve-stimulation device cuts Tourette's tics by over 25 percent.